CRP and coronary artery disorder: Ogiso et al. [12] showed that ezetimibe combined with pitavastatin for the treatment of coronary heart disease could effectively improve the efficacy, improve lipids and carotid plaque, reduce hs-CRP and CX3CR-1 expression, and improve endothelial cell function in patients, resulting in clinical benefits for patients with coronary heart pain, consistent with the findings of this paper.